1Pyrimidine synthesis is a processes
Pyrimidine synthesis is a five phase processes
2Purine synthesis is a process
Purine synthesis is a ten-step process
3While are easy for the body to metabolize and excrete, are not
While pyrimidines are easy for the body to metabolize and excrete, purines are not
4Purine synthesis involves intermediates that are to some cells.
Purine synthesis involves intermediates that are toxic to some cells.
5The final product of purine synthesis is
The final product of purine synthesis is uric acid
6At brush border there are cells that break down nuceleotides in the and
At brush border there are cells that break down nuceleotides in the duodenum and jejunum
7Enzymes that break down nucleotides are , , , and
Enzymes that break down nucleotides are ribonucleases, deoxyribonucleases, nucleosides, and phosphatases
8First, and
dissociate nucleotides from the
phosphodiester backbones
First, ribonucleases and deoxyribonucleases
dissociate nucleotides from the
phosphodiester backbones
9Then dissociate the Phosphate
(--P) from the nucleoside
Then phosphatases dissociate the Phosphate
(--P) from the nucleoside
10Finally, further break down
the nucleosides into and
.
Finally, nucleosidases further break down
the nucleosides into pentose sugars and
nitrogenous bases.
11Membrane transport proteins carry the products of nucleotide digestion into epithelial cells from the lumen via and transport
Membrane transport proteins carry the products of nucleotide digestion into epithelial cells from the lumen via active and secondary active transport
12The products are transported into the and then into the .
The products are transported into the interstitial fluid and then into the capillaries.
13The products are transported to the and other tissues wherethey undergo further metabolic processes
The products are transported to the liver and other tissues wherethey undergo further metabolic processes
14Nucleotides are the building blocks for what 3 important things?
1. Electron carriers FAD, NAD+, NADP+
2. Coenzyme A
3. cAMP
15NADP+ (used in processes -> high energy) is a phosphorylated form of NAD+ (used in processes)
NADP+ (used in anabolic processes -> high energy) is a phosphorylated form of NAD+ (used in catabolic processes)
16Coenzyme A, which feeds the TCA and is a cofactor in and
Coenzyme A, which feeds the TCA and is a cofactor in lipid synthesis and oxidation
17The salvage pathway involves activated ribose . The denovo pathway involves activated ribose
The salvage pathway involves activated ribose (PRPP) + base. The denovo pathway involves activated ribose (PRPP) + Amino Acid + ATP+CO2...
18If you ingest substances that have nitrogenous bases, then you can use those as building blocks for your nucleotides via pathway (saves energy).
If you ingest substances that have nitrogenous bases, then you can use those as building blocks for your nucleotides via salvage pathway (saves energy).
19If you do not have enough nitrogenous bases around, you can build your own nucleotides from scratch using very simple molecules ( ).
If you do not have enough nitrogenous bases around, you can build your own nucleotides from scratch using very simple molecules (de novo).
20Ribose 5-phosphate (R5P)-> Produced as an
intermediate of the and
Ribose 5-phosphate (R5P)-> Produced as an
intermediate of the pentose phosphate pathway and
glycolysis
21PRPP is produced by the of
ribose 5-phosphate by enzyme It involves the addition of that come from ATP
PRPP is produced by the pyrophosphorylation of
ribose 5-phosphate by enzyme PRPP-synthetase It involves the addition of pyrophosphates that come from ATP
22PRPP is allosterically controlled. It is activated by and as . It is inhibited by and feedback inhibition.
PRPP is allosterically controlled. It is activated by Pi and MG2+ as cofactor. It is inhibited by ADP and GDP feedback inhibition.
23PRPP is used in purine and pyrimidine synthesis in salvage and de novo pathways.
PRPP is used in BOTH purine and pyrimidine synthesis in BOTH salvage and de novo pathways.
24 are synthesized one at a time (or few at a time) directly onto the ring. Enzymes are present in larges complexes or
Purines are synthesized one at a time (or few at a time) directly onto the ring. Enzymes are present in larges complexes or metabolons
25The intermediate of purine synthesis is
The intermediate of purine synthesis is inosine monophosphate
26In the synthesis of pyrimidines, the ring is synthesized as and gets attached to ribose phosphate. It the gets converted to the pyrimidine nucleotides.
In the synthesis of pyrimidines, the ring is synthesized as orotate and gets attached to ribose phosphate. It the gets converted to the pyrimidine nucleotides.
27The is the primary organ that
produces nucleic acids.
The liver is the primary organ that
produces nucleic acids.
28The liver manages , which is a key
component of purine biosynthesis
The liver manages ammonia, which is a key
component of purine biosynthesis
29For de-novo purine synthesis, you need:
, , , ,
.
For de-novo purine synthesis, you need:
Glutamine, aspartate, glycine, CO2,
formate.
30TEST QUESTION!!!! Starting with PRPP, the first committed step
in the production of IMP is the addition of
an amino group from by the enzyme
to make
.
TEST QUESTION!!!! Starting with PRPP, the first committed step
in the production of IMP is the addition of
an amino group from Gln by the enzyme
PRPP glutamine amidotransferase to make
5-Phosphoribosyl-1-amine.
31There are steps from PRPP to formation of IMP
There are 11 steps from PRPP to formation of IMP
32After attachment of amino group from , is committed to go forward towards de novosynthesis of purines
After attachment of amino group from Gln, phosphoribosylamine is committed to go forward towards de novosynthesis of purines
33PRPP glutamine amidotransferase -> controlled and regulated
PRPP glutamine amidotransferase -> allosterically controlled and highly regulated
34PRPP is an allosteric FEED-FORWARD activator of
PRPP is an allosteric FEED-FORWARD activator of PRPP glutamine amidotransferase.
35PRPP is an allosteric activator of PRPP glutamine amidotransferase.
PRPP is an allosteric
FEED-FORWARD activator of PRPP glutamine amidotransferase.

36PRPP glutamine amidotransferase is allosterically inhibited by end-products -> , and
PRPP glutamine amidotransferase is allosterically inhibited by end-products -> IMP, AMP and GMP
37A chemotherapeutic drug, , also inhibits PRPP amidotransferase. It blocks purine synthesisand DNA synthesis.
A chemotherapeutic drug, 6-Mercaptopurine, also inhibits PRPP amidotransferase. It blocks purine synthesisand DNA synthesis.
38Once is formed, the path is committed to purine synthesis and there are 9 morereactions to form .
Once
phosphoribosylamine is formed, the path is committed to purine synthesis and there are 9 morereactions to form
IMP.

39The catalzying process of purine biosynthesis in by channeling to increase and
The catalzying process of purine biosynthesis in by channeling to increase biosynthesis efficiency and prevent degradation
40In the first step of the formation of IMP, ribose phosphate pyrophosphokinase converts ribose 5 phosphate to PRPP. This process is inhibited by
In the first step of the formation of IMP, ribose phosphate pyrophosphokinase converts ribose 5 phosphate to PRPP. This process is inhibited by
ADP. 
41In the second step of the formation of IMP, glutamine-PRPP-amidotransferase converts PRPP into 5-phosphoribosylamine. This process is activated by (feed-forward) and inhibited by , , and .
In the second step of the formation of IMP, glutamine-PRPP-amidotransferase converts PRPP into 5-phosphoribosylamine. This process is activated by
PRPP (feed-forward) and inhibited by
AMP,
GMP, and
IMP.

425-phosphoribosylamine is converted to IMP in 9 steps using , , , and as carbon donor
5-phosphoribosylamine is converted to IMP in 9 steps using
Gly,
Asp,
Gln, and
THF as carbon donor

43From IMP, and can be formed
From IMP,
AMP and
GMP can be formed

44IMP is converted to andeylosuccinate and then to AMP using an amino group from . Process is inhibited by (feedback)
IMP is converted to andeylosuccinate and then to AMP using an amino group from
ASP . Process is inhibited by
AMP (feedback)

45IMP is converted to XMP and then to GMP using an amino group from . Process is inhibited by (feedback).
IMP is converted to XMP and then to GMP using an amino group from
Gln . Process is inhibited by
GMP (feedback).

46In purine synthesis, and are used via
to start building the ring on the ribose.
In purine synthesis, Gly and (ATP) are used via glycinamide ribotide (GAR) Synthease
to start building the purine ring on the ribose.
47With GAR synthetase, reactions use charged to deliver
groups to the structure. That is a one-carbon transfer with a carbonyl group at and another at .
With GAR synthetase, reactions use charged tetra hydrofolate (THF) to deliver formyl
groups to the structure. That is a one-carbon transfer with a carbonyl group at (C8) and another at (C2).
48The synthesis of AMP requires
The synthesis of AMP requires GTP
49In AMP synthesis, the carbonyl group is replaced by an
In AMP synthesis, the carbonyl group is replaced by an amino group
50The synthesis of GMP requires
The synthesis of GMP requires ATP
51In GMP synthesis, the H in the is replaced by an group
In GMP synthesis, the H in the second ring is replaced by an amino group
52The formation of AMP energy! If you want to make AMP and you’re low in energy levels, it’s not a good idea to use up !
The formation of AMP uses energy! If you want to make AMP and you’re low in energy levels, it’s not a good idea to use up GTP!
53First, the carbonyl oxygen is activated by using energy of GTP and plugging in an -> makes .
First, the carbonyl oxygen is activated by using energy of GTP and plugging in an aspartate -> makes adenylosuccinate.
54GTP is a for Adenylosuccinate Synthetase -> pushes the reaction forward. Second, the carbon skeleton of aspartate is cut off, releasing and forming
GTP is a
positive effector for Adenylosuccinate Synthetase -> pushes the reaction forward. Second, the carbon skeleton of aspartate is cut off, releasing
fumarate and forming
AMP.
55The formation of process uses energy! If you want to make GMP and you’re low in energy levels, it’s not a good idea to
use-up
The formation of GMP process uses energy! If you want to make GMP and you’re low in energy levels, it’s not a good idea to
use-up ATP
56In the first step of GMP synthesis, the enzyme oxidizes IMP to form . This reaction is coupled with the reduction of
In the first step of GMP synthesis, the enzyme IMP dehydrogenase oxidizes IMP to form xantilate monophosphate (XMP). This reaction is coupled with the reduction of NAD+
57In the second step of GMP synthesis, the carbonyl just created is activated by and there’s the transfer of an amino group from .
In the second step of GMP synthesis, the carbonyl just created is activated by ATP and there’s the transfer of an amino group from glutamine.
58Cannot be stressed enough! AMP uses , GMP uses (what AA?)
Cannot be stressed enough! AMP uses ASP, GMP uses GLN (what AA?)
59The need of one type of to the other type is important for maintaining a proper balance
The need of one type of purine to produce the other type is important for maintaining a proper balance
60GTP is a positive effector of
GTP is a positive effector of adenylosuccinate synthetase
61 is an essential water-soluble vitamin (absorbed in duodenum))
Folate (Vit B9) is an essential water-soluble vitamin (absorbed in duodenum))
62Folate mainly comes from , nuts, meats
Folate mainly comes from leafy green vegtables, nuts, meats
63What is the precursor for vit B9 synth?
THF
64 is a biproduct of methanol (toxic), so folate can
help to detoxify from methanol poisoning
Formic acid is a biproduct of methanol (toxic), so folate can
help to detoxify from methanol poisoning
65B9 is needed for and synthesis. It is also involved in amino acid snthesis, nuceloprotein synthesis, catecholamine synthesis, and formic acid.
B9 is needed for purine and pyrimindine synthesis. It is also involved in amino acid snthesis, nuceloprotein synthesis, catecholamine synthesis, and formic acid.
66Microorganisms convert pteridine precursors and para-aminobenzoic acid into folic acid. Folic acid
synthesis is inhibited by
Microorganisms convert pteridine precursors and para-aminobenzoic acid into folic acid. Folic acid
synthesis is inhibited by sulfonamides antibiotics.
67Folate is converted to dihydrofolate (DHF) by
Folate is converted to dihydrofolate (DHF) by dihydrofolate reductase (DHFR)
68The antibiotic trimethoprim inhibits Perfers bacterial to human.
The antibiotic trimethoprim inhibits DHFR Perfers bacterial DHFR to human.
69 groups carried by THF
One-carbon groups carried by THF
70THF is a 6-methylpterin derivative linked in sequence to and
residues (n= 1 –6)
THF is a 6-methylpterin derivative linked in sequence to p-aminobenzoic acid (PABA) and Glutamate (Glu)
residues (n= 1 –6)
71Sufonamides (sulfa drugs) are antibiotics that are analogs to and competitively inhibit bacterial
synthesis of THF at the PABA incorporation step.
Sufonamides (sulfa drugs) are antibiotics that are analogs to PABA and competitively inhibit bacterial
synthesis of THF at the PABA incorporation step.
72THF is important in the transfer of units.
THF is important in the transfer of 1C units.
73THF is derived from , a doubly oxidized form
that must be enzymatically reduced before it becomes an
active coenzyme.
THF is derived from folic acid (Vit B9), a doubly oxidized form
that must be enzymatically reduced before it becomes an
active coenzyme.
74Both reactions that form tetrahydrolate from folate are catalyzed by
Both reactions that form tetrahydrolate from folate are catalyzed by Dihydrofolate reductase
(DHFR)
75C1 units are covalently attached to THF at positions ,
or both and .
C1 units are covalently attached to THF at positions N5,
N10 or both N5 and N10.
76Folate is involved in and is sometimes called
Folate is involved in single carbon transfer reactions and is sometimes called B9
77Deficiency in can result in megaloblastic anemia, cardiovascular disease, and birth defects
Deficiency in folate metabolism can result in megaloblastic anemia, cardiovascular disease, and birth defects
78IMP biosynthesis is an energetically consuming process that
requires the hydrolysis of ATPs.
IMP biosynthesis is an energetically consuming process that
requires the hydrolysis of 6 ATPs.
79 in purine rings are from glutamine
N9 in purine rings are from glutamine
80Everything starts with
Metabolic contribution of
to the purine biosynthesis and
other anabolic pathways
Everything starts with PRPP
Metabolic contribution of PRPP
to the purine biosynthesis and
other anabolic pathways
81The activity of PRPP synthetase varies with the
concentrations of several metabolites, including and
, which are activators, and and , which
are inhibitors.
The activity of PRPP synthetase varies with the
concentrations of several metabolites, including PPi and
2,3-BPG, which are activators, and ADP and GDP, which
are inhibitors.
82***Test Question
The pathways synthesizing , , and are
regulated in most cells -> control the total amounts of
purines produced and also coordinate the relative
amounts of and .
***Test Question
The pathways synthesizing IMP, ATP, and GTP are
regulated in most cells -> control the total amounts of
purines produced and also coordinate the relative
amounts of ATP and GTP.
83-Gln-PRPP-amidotransferase is controlled by feedback
inhibition ( , , ).
-Gln-PRPP-amidotransferase is controlled by feedback
inhibition (AMP, GMP, IMP).
84-The branched portion of the pathway from IMP: inhibition
- High inhibits adenylosuccinatesynthase;
- Similarly, high inhibits IMP
dehydrogenase.
-The branched portion of the pathway from IMP:
feedback inhibition
- High
[AMP] inhibits adenylosuccinatesynthase;
- Similarly, high
[GMP] inhibits IMP
dehydrogenase.

85Reciprocal regulation via GTP and ATP:
- stimulates adenylosuccinate
synthase.
- stimulates XMP-glutamine
amidotransferase.
Reciprocal regulation via GTP and ATP:
- GTP stimulates adenylosuccinate
synthase.
-ATP stimulates XMP-glutamine
amidotransferase.
86The monophosphates are converted to
using respective specific
kinases (Adenylate kinase, Guanylate
kinase)
The monophosphates are converted to
diphosphates using respective specific
kinases (Adenylate kinase, Guanylate
kinase)
87Purine diphosphates are converted
to triphosphates in reactions
catalyzed by
Purine diphosphates are converted
to triphosphates in reactions
catalyzed by nucleoside
diphosphokinase (NDPK).
88 catalyzes conversion of all
nucleoside diphosphates to
nucleoside triphosphates.
NDPK catalyzes conversion of all
nucleoside diphosphates to
nucleoside triphosphates.